Byungchan Moon | Health Professions | Best Researcher Award

Posted on by Book of Award

Mr. Byungchan Moon | Health Professions | Best Researcher Award

Global Procurement Development Institute | South Korea

Author Profile

Orcid

Early Academic Pursuits 🎓

Mr. Byungchan Moon's academic journey is rooted in a commitment to healthcare and international development. Currently pursuing a Doctorate in Health Sciences at Korea University (2025), he has also enriched his expertise by completing the International Bidding & Overseas Public Procurement Management Course at KAIST Business School in 2018. These milestones reflect his dedication to mastering the intricacies of global healthcare expansion.

Professional Endeavors 🌍

With a focus on integrating public and private sectors, Mr. Moon has held pivotal roles, including Head of Public Business at the Global Procurement Development Institute since 2021. Previously, he contributed as a Research Associate for the International Bidding and Procurement Team at Yulchon LLC (2018–2021). His professional trajectory underscores his leadership in navigating international healthcare markets and procurement strategies.

Contributions and Research Focus 🏥

Mr. Moon's expertise spans healthcare policy development, IT solutions, and public procurement for the healthcare industry. Notable contributions include:

  • Supporting Korean hospitals' entry into global markets such as Qatar and Russia.
  • Establishing a big data-driven consulting platform to access the U.S. federal government procurement market.
  • Crafting innovative public procurement policies for SMEs in Costa Rica.
    His projects emphasize fostering international collaboration and driving innovation in healthcare systems.

Accolades and Recognition 🏅

Mr. Moon is widely recognized for his ability to bridge gaps between domestic and international healthcare sectors. His efforts in supporting international bidding and guiding strategic expansions have earned him acknowledgment as a thought leader in global healthcare policy and business development.

Impact and Influence 🌟

Through his work, Mr. Moon has significantly influenced healthcare globalization efforts, paving the way for Korean healthcare providers and companies to thrive internationally. His strategies in public procurement and healthcare IT solutions have not only fostered economic growth but also enhanced the accessibility of advanced healthcare services worldwide.

Legacy and Future Contributions 🔮

Looking ahead, Mr. Moon aims to continue shaping the future of healthcare by driving innovation and collaboration across borders. His academic pursuits and professional endeavors position him as a trailblazer, ensuring that his legacy in global healthcare expansion and policy development will inspire generations to come.

 

Publications

📄 A Study on Adolescent Smoking Prevention and Cessation Policies: Based on the Propensity Score Matching–Difference-in-Differences Method
Publication: Healthcare (MDPI)
Publication Year: 2024
Authors: Seokmin Ji, Byungchan Moon, Young Gyu Kwon, Kyu-Min Kim

 

Yannick Allanore | Medicine and Dentistry | Best Research Article Award

Posted on by Book of Award

Prof. Yannick Allanore | Medicine and Dentistry | Best Research Article Award

Université Paris Cité | France

Author Profile

Scopus

Early Academic Pursuits

Yannick Allanore commenced his academic journey at Paris Descartes University, obtaining a Master's degree in 1999, followed swiftly by a Medical Doctor certification in 2000. His commitment to specialization in Rheumatology led to a Certification in Rheumatology in 2001. His profound interest in the field culminated in a thesis on "Oxidative stress and systemic sclerosis," earning him a Physician Doctor title in 2004.

Professional Endeavors

His academic tenure unfolded as an Assistant Professor at Paris Descartes University's Rheumatology department at Cochin Hospital from 2005 to 2008. Allanore's research prowess was acknowledged with a Research Habilitation in 2005, focusing on the pathogenesis of systemic sclerosis. Subsequently, he served as a Post-doctoral researcher at INSERM U781 and U1016, delving into the genetic bases and chronic inflammation of systemic sclerosis.

Contributions and Research Focus

Allanore leads a groundbreaking research team at Institut Cochin, delving into pathogenesis and innovative therapies for fibro-inflammatory rheumatic diseases since 2018. His research delves into genetic and pathophysiological aspects of systemic sclerosis, cardio-pulmonary involvement, clinical trials, and endothelial progenitor cells in rheumatic diseases.

Accolades and Recognition

Professor Allanore boasts a substantial publication record, exceeding 480 papers in peer-reviewed journals, showcasing an impressive H-Index of 71. His contributions have earned him memberships in esteemed societies such as the French Rheumatology Society, American College of Rheumatology, and significant roles within EUSTAR and the World Scleroderma Foundation.

Impact and Influence

His leadership roles, including former chairman of EUSTAR and current vice-director of Institut Cochin, testify to his impact on the global rheumatology community. Allanore's multifaceted approach—integrating clinical research, genetic studies, cellular biology, and animal model platforms—underlines his comprehensive influence on understanding and treating chronic inflammatory rheumatic diseases.

Legacy and Future Contributions

Yannick Allanore's legacy lies in his pivotal contributions to unraveling the complexities of systemic sclerosis and related conditions. His leadership in research and academia continues to pave the way for innovative therapies and a deeper comprehension of these debilitating diseases. As vice-director of Institut Cochin, his ongoing dedication promises further advancements in the field of rheumatology.

Notable Publications

Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysis 2023 (1)

Characteristics of patients with difficult-to-treat rheumatoid arthritis in a French single-centre hospital 2023 (2)

Comparison of subcutaneous and oral methotrexate initiation in rheumatoid arthritis in current practice 2023 (1)